  | Limpens, M., Derenne, A., Burtea, C., Laurent, S., Legrand, A., Wilton, S., Belayew, A., Coppée, F., Decleves, A.-E., & Tassin, A. (June 2024). Selection of peptides for a muscle-targeted delivery of ASOs directed against DUX4 mRNAs through complementary approaches in silico, in vitro and in vivo [Poster presentation]. 31th Annual FSHD Society International Research Congress, Denver, United States - Colorado.  Editorial reviewed |
Nguyen, T.-H., Limpens, M., Bouhmidi, S., Paprzycki, L., Legrand, A., Decleves, A.-E., Heher, P., Belayew, A., Banerji, C., Zammit, P., & Tassin, A. (26 April 2024). Hypoxia and Hypoxia-Inducible Factor Signaling in Muscular Dystrophies [Paper presentation]. Physphar Spring Meeting 2024 - Closing lecture. Peer reviewed |
 | Szczepanski, S., Limpens, M., Blommaert, V., Jenart, V., Legrand, A., Decleves, A.-E., & Tassin, A. (22 April 2024). Adiponectin pathway in murine models of skeletal muscle deconditioning and reconditioning [Poster presentation]. 8th International congress Myology. |
 | Limpens, M., Derenne, A., Burtea, C., Laurent, S., Legrand, A., Wilton, S., Belayew, A., Coppée, F., Decleves, A.-E., & Tassin, A. (April 2024). Selection of peptides for a muscle-targeted delivery of ASOs directed against DUX4 mRNAs through complementary approaches in silico, in vitro and in vivo [Poster presentation]. 8th International congress Myology, Paris, France. Editorial reviewed |
 | Nguyen, T. H., Limpens, M., Bouhmidi, S., Paprzycki, L., Legrand, A., Decleves, A.-E., Heher, P., Belayew, A., Banerji, C. R. S., Zammit, P. S., & Tassin, A. (15 March 2024). The DUX4-HIF1α Axis in Murine and Human Muscle Cells: A Link More Complex Than Expected. International Journal of Molecular Sciences, 25 (332). doi:10.20944/preprints202211.0532.v2 Peer reviewed vérifié par ORBi Dataset : https://doi.org/10.3390/ijms25063327 |
Limpens, M., Derenne, A., Burtea, C., Laurent, S., Legrand, A., Wilton, S., Belayew, A., Coppée, F., Decleves, A.-E., & Tassin, A. (2023). Selection of peptides for a muscle-targeted delivery of ASO directed against DUX4 mRNAs through complementary approaches in silico, in vitro and in vivo [Paper presentation]. Physphar Spring meeting (2023), Brussels, Belgium. Editorial reviewed |
 | Szczepanski, S., Limpens, M., Decleves, A.-E., Legrand, A., & Tassin, A. (12 September 2022). Adiponectin pathway in a murine model of disuse muscle atrophy: in in vivo study [Poster presentation]. 7th International Myology Congress, Nice, France. Editorial reviewed |
 | LIMPENS, M., Derenne, A., Burtea, C., Legrand, A., Decleves, A.-E., Coppée, F., & Tassin, A. (17 June 2022). Towards a muscle-targeted delivery of antisense agents against DUX4 [Poster presentation]. The 29th FSHD Society's annual International Research Congress 2022. Editorial reviewed |
 | Szczepanski, S., LIMPENS, M., Decleves, A.-E., Legrand, A., & Tassin, A. (29 April 2022). Adiponectin pathway in a murine model of disuse muscle atrophy: an in vivo study ? [Poster presentation]. Spring Meeting of the Belgian Society of Physiology and Pharmacology. Editorial reviewed |